A web portal named OFC-SV was developed to support interpretation of structural variants in non-syndromic orofacial cleft genomic data. The authors reported that the portal hosts data derived from The Gabriella Miller Kids First Pediatric Research Program. The project focuses on cohorts of children of African and Asian ancestry, offering a user-centered interface to query variant annotations and regulatory context. The portal URL was provided by the study team on the preprint page.
The dataset provenance is explicit. Data sources and links to supplementary materials and any available code were posted alongside the preprint. The article is a preprint and has not been peer reviewed; the authors declared no competing interests. These provenance details matter to clinicians and researchers seeking to reuse or reanalyze the findings, because preprint datasets can change after formal review.
The team placed 41 candidate SV genes into the portal for exploration. Thirteen of those genes were reported to share regulatory perturbations previously described in the literature as single-nucleotide variant (SNV) genes. That co-occurrence suggests overlapping regulatory mechanisms across different variant classes, investigators reported. The portal therefore provides a consolidated view where users can examine genes implicated by structural variation alongside existing SNV-based evidence.
The abstract did not enumerate each gene in text, nor did it list specific variant coordinates or per-gene evidence levels within the abstract itself. The study team pointed users to the portal and to supplementary files for gene-level detail. Users interested in gene lists, variant calls, or locus-specific annotations should consult the portal or the supplementary material linked on the preprint page.
A notable capability of OFC-SV is its visualization layer for regulatory and epigenomic context. The portal reportedly captures epigenomic disruptions and maps complex oligogenic interactions in regulatory pathways. Visualized regulatory pathways translate computational signals into biological interpretations, the authors wrote. This is intended to help researchers move from raw SV calls to hypotheses about disrupted regulatory elements, interacting loci, and pathway-level mechanisms.
The portal emphasizes regulatory perturbation rather than only coding disruption. Users can therefore inspect noncoding SV impacts in the context of chromatin or regulatory annotations, according to the abstract. The preprint text did not specify the exact epigenomic datasets integrated into the portal—readers should consult the portal or supplementary materials for that level of detail. The portal is described as user-friendly, designed for convenient translation of computational signals into biological interpretations, according to the authors.
The OFC-SV resource is publicly linked on the preprint page. The authors declared funding from the NIH Common Fund and from NIDCR (grant 5R03DE033083). The preprint notes copyright and license terms; the authors granted bioRxiv a license to display the preprint under a CC-BY-NC-ND 4.0 International license. The manuscript is posted as a preprint; it has not been certified by peer review.
The authors stated no competing interests. Supplementary material, data, and code links were provided on the article webpage for users who wish to examine the underlying data or reproduce analyses.
Limitations and unresolved items reported in the abstract and page metadata are concrete. The abstract did not present experimental validation results for the candidate SV genes, nor did it provide detailed method parameters in the abstract text. The portal claims to map epigenomic disruptions and oligogenic interactions, but the abstract itself does not enumerate which epigenomic assays or pathway databases were used for those visualizations. Researchers and clinicians should therefore treat the portal and its candidate gene set as an exploratory resource pending peer review and further validation.
The work raises specific, open questions documented by the authors: which of the 41 candidate SV genes will validate in functional assays, how shared regulatory perturbations relate to phenotypic severity in diverse populations, and whether portal-derived hypotheses will converge with future experimental or clinical studies. These represent measurable next steps that remain to be addressed in follow-up work or during peer review.